ESC 365 - Sirolimus vs paclitaxel for femoropopliteal peripheral artery disease

Back

ESC2025 Premium Access

Sirolimus vs paclitaxel for femoropopliteal peripheral artery disease - The limus flow randomized trial

Session: Peripheral angioplasty and complications

Topic: Intervention

Speaker: Professor C. Rammos (Essen, DE)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Christos Rammos

University of Duisburg-Essen - West-German Heart and Vascular Centre, Essen (Germany)

2 presentations

1 follower

6 more presentations in this session

Pathology of balloon angioplasty for below the knee arteries in patients with chronic limb threatening ischemia

Speaker: Doctor M. Shiozaki (Kanagawa, JP)

The predictors of clinical outcome in the patients undergoing endovascular intervention for lower extremity peripheral arterial disease

Speaker: Professor B. Kim (Seoul, KR)

Major adverse limb and cardiac events after iatrogenic and atherosclerotic radial artery recanalizations

Speaker: Associate Professor Z. Ruzsa (Szeged, HU)

Clinical impact of endovascular therapy with paclitaxel-based strategy for femoropopliteal lesions in chronic limb-threatening ischaemia

Speaker: Mr H. Nohara (Sakai, JP)

Long-term prognosis after bypass surgery versus endovascular therapy in chronic hemodialysis patients with peripheral artery disease -10-year follow-up study

Speaker: Doctor Y. Kumada (Kasamatsu, JP)

Access the full session

Peripheral angioplasty and complications

Speakers: Professor C. Rammos, Doctor M. Shiozaki, Professor B. Kim, Associate Professor Z. Ruzsa, Mr H. Nohara...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources